This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, M. L. Articles by Kurz, K. D. Search for Related Content PubMed PubMed Citation Articles by Cohen, M. L. Articles by Kurz, K. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB METHOXAMINE HYDROCHLORIDE

Hypertension, Vol 5, 676-681, Copyright © 1983 by American Heart Association

ARTICLES

Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats

ML Cohen, RW Fuller and KD Kurz

In vitro affinity for vascular 5HT2 and alpha receptors was determined for several compounds (spiperone, ketanserin, mianserin, trazodone, mepiprazole, benzoctamine, m-trifluoro-methylphenylpiperazine, m- chlorophenylpiperazine, and 1-(1-naphthyl)piperazine) known to interact with serotonin receptors. All compounds competitively inhibited 5HT2 and alpha receptors with differing degrees of selectively. Based on these observations, ketanserin, benzoctamine, and 1(1- naphthyl)piperazine were evaluated as antihypertensive agents in spontaneously hypertensive rats (SHR). Of these compounds, 1-(1- naphthyl)piperazine was a highly selective 5HT2 receptor antagonist with a ratio of 5HT2 to alpha receptor affinity of greater than 2000. The ratio of 5HT2 to alpha receptor affinity for ketanserin and benzoctamine was 63 and 16, respectively. However, the order of affinity toward 5HT2 receptors was ketanserin greater than 1-(1- naphthyl)piperazine greater than benzoctamine whereas the order of affinity toward alpha receptors was ketanserin greater than benzoctamine greater than 1-(1-naphthyl)piperazine. A similar order of potency toward both 5HT2 and alpha receptors was found in pithed SHR based on antagonism of the pressor response to serotonin and methoxamine, respectively. In the SHR, maximum blood pressure reduction at a dose of 10 mg/kg i.p. was approximately 65 and 30 mm Hg for ketanserin and benzoctamine, respectively; 1-(1-naphthyl)piperazine did not affect blood pressure. Thus, blood pressure reduction more closely paralleled the in vitro and in vivo potency of these agents toward vascular alpha rather than 5HT2 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				S. W. Watts The love of a lifetime: 5-HT in the cardiovascular system Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R252 - R256. [Abstract] [Full Text] [PDF]

				S. W. Watts Serotonin-Induced Contraction in Mesenteric Resistance Arteries: Signaling and Changes in Deoxycorticosterone Acetate-Salt Hypertension Hypertension, March 1, 2002; 39(3): 825 - 829. [Abstract] [Full Text] [PDF]

				S. W. Watts and G. D. Fink 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H944 - H952. [Abstract] [Full Text] [PDF]

				K. E. Scrogin, A. K. Johnson, and H. A. Schmid Multiple receptor subtypes mediate the effects of serotonin on rat subfornical organ neurons Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R2035 - R2042. [Abstract] [Full Text] [PDF]